Nano Mobile Healthcare Stock Fundamentals
| VNTH Stock | USD 0.0002 0.0001 100.00% |
Nano Mobile Healthcare fundamentals help investors to digest information that contributes to Nano Mobile's financial success or failures. It also enables traders to predict the movement of Nano Pink Sheet. The fundamental analysis module provides a way to measure Nano Mobile's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nano Mobile pink sheet.
Nano |
Nano Mobile Healthcare Company Return On Asset Analysis
Nano Mobile's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Nano Mobile Return On Asset | -15.78 |
Most of Nano Mobile's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nano Mobile Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Nano Mobile Healthcare has a Return On Asset of -15.778. This is 80.32% higher than that of the Health Care Technology sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Nano Mobile Healthcare Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nano Mobile's current stock value. Our valuation model uses many indicators to compare Nano Mobile value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nano Mobile competition to find correlations between indicators driving Nano Mobile's intrinsic value. More Info.Nano Mobile Healthcare is rated below average in return on asset category among its peers. It also is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nano Mobile by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nano Mobile's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nano Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nano Mobile's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nano Mobile could also be used in its relative valuation, which is a method of valuing Nano Mobile by comparing valuation metrics of similar companies.Nano Mobile is currently under evaluation in return on asset category among its peers.
Nano Fundamentals
| Return On Asset | -15.78 | |||
| Current Valuation | 1.75 M | |||
| Shares Outstanding | 803.66 M | |||
| Shares Owned By Insiders | 12.82 % | |||
| Price To Earning | (0.01) X | |||
| EBITDA | (1.31 M) | |||
| Net Income | (4.6 M) | |||
| Cash And Equivalents | 485 | |||
| Debt To Equity | 0.64 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (1.59 M) | |||
| Earnings Per Share | (0.03) X | |||
| Beta | -0.63 | |||
| Market Capitalization | 482.19 K | |||
| Total Asset | 10.3 K | |||
| Retained Earnings | (16.77 M) | |||
| Working Capital | (11.81 M) | |||
| Current Asset | 58 K | |||
| Current Liabilities | 11.87 M | |||
| Net Asset | 10.3 K |
About Nano Mobile Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nano Mobile Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nano Mobile using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nano Mobile Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Nano Mobile Healthcare, Inc. operates as a mobile health technology company in the United States. Nano Mobile Healthcare, Inc. is a subsidiary of Nanobeak, LLC. Nano Mobile operates under Health Information Services classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Nano Pink Sheet
Nano Mobile financial ratios help investors to determine whether Nano Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nano with respect to the benefits of owning Nano Mobile security.